Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18355329rdf:typepubmed:Citationlld:pubmed
pubmed-article:18355329lifeskim:mentionsumls-concept:C0026339lld:lifeskim
pubmed-article:18355329lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:18355329lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:18355329lifeskim:mentionsumls-concept:C0011860lld:lifeskim
pubmed-article:18355329lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:18355329lifeskim:mentionsumls-concept:C0017725lld:lifeskim
pubmed-article:18355329lifeskim:mentionsumls-concept:C0935929lld:lifeskim
pubmed-article:18355329lifeskim:mentionsumls-concept:C0580545lld:lifeskim
pubmed-article:18355329lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:18355329lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:18355329lifeskim:mentionsumls-concept:C0068450lld:lifeskim
pubmed-article:18355329pubmed:issue11lld:pubmed
pubmed-article:18355329pubmed:dateCreated2008-12-2lld:pubmed
pubmed-article:18355329pubmed:abstractTextThe present investigation was designed to determine the in vivo antidiabetic effect of naringenin (NG) in normoglycaemic and diabetic rat models through blood glucose (GLU) measurements following acute and subchronic time periods. Possible modes of action of NG were investigated and its acute toxicity determined.lld:pubmed
pubmed-article:18355329pubmed:languageenglld:pubmed
pubmed-article:18355329pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18355329pubmed:citationSubsetIMlld:pubmed
pubmed-article:18355329pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18355329pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18355329pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18355329pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18355329pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18355329pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18355329pubmed:statusMEDLINElld:pubmed
pubmed-article:18355329pubmed:monthNovlld:pubmed
pubmed-article:18355329pubmed:issn1463-1326lld:pubmed
pubmed-article:18355329pubmed:authorpubmed-author:BinnieMMlld:pubmed
pubmed-article:18355329pubmed:authorpubmed-author:Villalobos-Mo...lld:pubmed
pubmed-article:18355329pubmed:authorpubmed-author:WebsterS PSPlld:pubmed
pubmed-article:18355329pubmed:authorpubmed-author:Navarrete-Váz...lld:pubmed
pubmed-article:18355329pubmed:authorpubmed-author:Ortiz-Andrade...lld:pubmed
pubmed-article:18355329pubmed:authorpubmed-author:Estrada-SotoS...lld:pubmed
pubmed-article:18355329pubmed:authorpubmed-author:García-Jiméne...lld:pubmed
pubmed-article:18355329pubmed:authorpubmed-author:Sánchez-Salga...lld:pubmed
pubmed-article:18355329pubmed:authorpubmed-author:León-RiveraIIlld:pubmed
pubmed-article:18355329pubmed:authorpubmed-author:Cigarroa-Vázq...lld:pubmed
pubmed-article:18355329pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18355329pubmed:volume10lld:pubmed
pubmed-article:18355329pubmed:ownerNLMlld:pubmed
pubmed-article:18355329pubmed:authorsCompleteYlld:pubmed
pubmed-article:18355329pubmed:pagination1097-104lld:pubmed
pubmed-article:18355329pubmed:dateRevised2009-11-3lld:pubmed
pubmed-article:18355329pubmed:meshHeadingpubmed-meshheading:18355329...lld:pubmed
pubmed-article:18355329pubmed:meshHeadingpubmed-meshheading:18355329...lld:pubmed
pubmed-article:18355329pubmed:meshHeadingpubmed-meshheading:18355329...lld:pubmed
pubmed-article:18355329pubmed:meshHeadingpubmed-meshheading:18355329...lld:pubmed
pubmed-article:18355329pubmed:meshHeadingpubmed-meshheading:18355329...lld:pubmed
pubmed-article:18355329pubmed:meshHeadingpubmed-meshheading:18355329...lld:pubmed
pubmed-article:18355329pubmed:meshHeadingpubmed-meshheading:18355329...lld:pubmed
pubmed-article:18355329pubmed:meshHeadingpubmed-meshheading:18355329...lld:pubmed
pubmed-article:18355329pubmed:meshHeadingpubmed-meshheading:18355329...lld:pubmed
pubmed-article:18355329pubmed:meshHeadingpubmed-meshheading:18355329...lld:pubmed
pubmed-article:18355329pubmed:meshHeadingpubmed-meshheading:18355329...lld:pubmed
pubmed-article:18355329pubmed:meshHeadingpubmed-meshheading:18355329...lld:pubmed
pubmed-article:18355329pubmed:meshHeadingpubmed-meshheading:18355329...lld:pubmed
pubmed-article:18355329pubmed:meshHeadingpubmed-meshheading:18355329...lld:pubmed
pubmed-article:18355329pubmed:meshHeadingpubmed-meshheading:18355329...lld:pubmed
pubmed-article:18355329pubmed:year2008lld:pubmed
pubmed-article:18355329pubmed:articleTitleAntidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation.lld:pubmed
pubmed-article:18355329pubmed:affiliationFacultad de Farmacia, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, Mexico.lld:pubmed
pubmed-article:18355329pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18355329pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:18355329pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed